You just read:

Novoteris Investigator Receives Health Canada Clearance to Start a Phase 2a Clinical Trial of its Thiolanox® Nitric Oxide for the Treatment of Non-Tuberculous Mycobacteria (NTM)

News provided by

Novoteris, LLC

Oct 31, 2017, 08:40 ET